Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, moiety A and moiety B either a monocyclic ring or a polycyclic fused ring system; each of X1 to X4, Z1, and Z2 is C or N; K1 is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), or Si(R?)(R?); L1 is a direct bond or a linking group; each R?, R?, RA and RB is hydrogen or a General Substituent; and LA is coordinated to a metal M. In addition, RA or RB alone or in combination with a substituent of L1 form a 7-membered ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are neutral Pt or Pd organometallic compounds comprising a tetradentate ligand, wherein the organometallic compound comprises at least one Pt—C or Pd—C bond. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.

Abstract: Provided are compounds comprising ligands LA that are ligands of Pt and Ir complexes for OLED applications. Also provided are formulations comprising these compounds comprising ligands LA that are ligands of Pt and Ir complexes for OLED applications. Further provided are OLEDs and related consumer products that utilize these compounds comprising ligands LA that are ligands of Pt and Ir complexes for OLED applications.

Abstract: A compound comprising a first ligand LA of Formula I, and a structure of Formula II, is provided. Formula II is fused to ring A by two adjacent ones of X1 to X4, which are both C. In Formula I and II, X1 to X4 are C or N; K is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); moiety E is H or D; C1 is C; each of moiety B and moiety C is independently a ring or a fused ring system; each R?, R?, RA, RB, and RC is hydrogen or a General Substituent; and LA is coordinated to a metal M with an atomic mass of at least 40. If moiety C is a 6-membered ring, then moiety B is a fused ring system and then all the RC substituents comprise two or more of combined carbon atoms. Formulations, OLEDs, and consumer product including the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, where at least one RA or RB substituent has a structure according to Formula II, is provided. In Formula I and Formula II, moieties A, B, and C are independently rings or a fused-ring systems; each of X1, X2, Z1, Z2, X3, and Z4 is C or N; K a direct bond or selected from the group consisting of O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); L is a linker; n is 1, 2, or 3; each R, R?, R?, R?, RA, RB, RC, RL, and RL? is independently hydrogen or a General Substituent; and at least one R or R? is a fully or partially fluorinated alkyl group, a fully or partially fluorinated cycloalkyl group, a cyano group, a cyanoalkyl group, or a silyl group. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are compounds having a formula of Ir(LA)p(LB)q(LC)r, wherein LA has a structure of Formula IA: LB has a structure of Formula IB: . Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: Provided are compounds comprising a first ligand LA which comprises a first B atom and a first N atom; the first B atom forms exactly three single bonds to three atoms selected from the group consisting of C and N; and one of the three atoms is the first N atom; the first N atom is a ring atom of a first 6-membered ring, and B is not a ring atom of the first 6-membered ring; the first 6-membered ring comprises at least two double bonds in at least one Lewis structural drawing; LA is coordinated to a metal M selected from the group consisting of Os, Ir, Pd, Pt, Cu, Ag, and Au; and LA may be joined with other ligands to comprise a bidentate, tridentate, tetradentate, pentadentate, or hexadentate ligand. Also provided are formulations comprising these compounds and OLEDs and related consumer products that utilize these compounds.

Abstract: A compound comprising a first ligand LA comprising a structure of Formula I, is provided. In Formula I, moieties A, B, C, and D are each independently a monocyclic ring or a multicyclic fused ring system; each of X1 to X8 is C or N; each independently represents a single bond or a double bond; each of L1, L2, L3, and L4 is independently a direct bond or a linking group; each R, R?, R?, RA, RB, RC, and RD is a hydrogen or a General Substituent; any two adjacent R, R?, R?, RA, RB, RC, and RD may be joined or fused to form a ring; and LA is coordinated to a transition metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are compounds comprising a 9-membered ring to which four 6-membered carbocyclic or heterocyclic aromatic rings as well as one further 5-membered or 6-membered heterocyclic ring are fused. Also provided are formulations comprising these compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these compounds.

Abstract: Provided is a compound including a first ligand LA of Formula I In Formula I, ring C is a 5- or 6-membered ring; each of X1 to X8 is C or N; one of X1 to X4 is C and is connected to ring C, and one of X1 to X4 is N and is coordinated to a metal M; Y is a divalent linker; K is a direct bond, O, or S; each R?, R?, RA, RB, and RC is hydrogen or a general substituent; at least one of RA or RB comprises an electron-withdrawing group; at least one of RB is a cyclic group; and metal M is selected from Os, Ir, Pd, Pt, Cu, Ag, and Au. Formulations, devices, and consumer products comprising the compound are also disclosed.

Abstract: Disclosed is a compound including a ligand LA of Formula I where each of moiety A and moiety B is independently a monocyclic or polycyclic ring structure including 5-membered and/or 6-membered carbocyclic or heterocyclic rings; where moiety B includes a structure of Formula II These compounds are useful as a component in the emissive layer of OLEDs.

Abstract: A compound including a first ligand LA of Formula I, is provided. In Formula I, each of moiety A and moiety B independently represents monocyclic or polycyclic rings; one of Z1 and Z2 is C and the other is N; K is a direct bond, O, or S; at least one RA or RB has a structure of Formula II, where at least two of X1 to X4 are C; L is a direct bond or an organic linker; each R, R?, R?, RA, RB, and RC is a hydrogen or a General Substituent; and LA is coordinated to a metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided is an organometallic compound including a first ligand LA selected from In ligand LA, each of Y1 to Y10 is carbon or nitrogen; moiety B is a monocyclic or polycyclic fused ring structure including 5-membered and/or 6-membered rings; any two RA and RB can be fused or joined to form a ring; X is selected from O, S, Se, or NR; each RA and RB is independently hydrogen or a substituent selected from the general substituent defined herein; at least one R, RA, or RB is deuterium or a linking group between LA and another ligand that includes a deuterium substituted aromatic ring; and LA is coordinated to a metal M, selected from Os, Pd, Pt, Ir, Cu, Ag, or Au; and the compound is capable of emitting light with a peak maximum wavelength (?max)?700 nm at room temperature.

Abstract: Provided are organometallic compounds comprising a first ligand LA comprising a multicyclic fused ring system wherein ligand LA is coordinated to a metal M; and wherein M is selected from the group consisting of Os, Ir, Pd, Pt, Cu, Ag, and Au. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound including a first bidentate ligand LA that includes a structure of Formula I, are provided. The ligand LA is coordinated to a metal M and can be joined with other ligands. In Formula I, in addition to some exclusions, each of X1, X2, X3, and X4 is C or N; two R1, R2, and R3 can be joined or fused to form a ring; and each R1, R2, and R3 is independently a group containing the metal M, a hydrogen, or a General Substituent defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: An organometallic compound including a first ligand LA selected from is provided. In ligand LA, each of Y1 to Y10 is carbon or nitrogen; moiety B is a monocyclic or polycyclic fused ring structure comprising 5-membered and/or 6-membered rings; any two RA and RB can be fused or joined to form a ring; X is selected from O, S, Se, or NR; each RA and RB is independently hydrogen or a General Substituent; at least one R, RA, or RB is deuterium or a linking group between LA and another ligand that includes a deuterium substituted aromatic ring; and LA is coordinated to a metal M, selected from Os, Pd, Pt, Ir, Cu, Ag, or Au; and the compound is capable of emitting light with a peak maximum wavelength (?max)?700 nm at room temperature.

Abstract: Provided are compounds comprising a ligand LA, wherein the ligand LA comprises a structure of wherein: moiety A is a monocyclic or polycyclic fused ring system comprising one or more 5-membered and/or 6-membered carbocyclic or heterocyclic rings; at least one of R or R? is fluorine; n is 0, 1, 2, or 3; each of RA, R, and R? is independently a hydrogen or a substituent and combinations thereof; wherein the ligand LA is coordinated to a metal M selected from the group consisting of Os, Ir, Pd, Pt, Cu, Ag, and Au, Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound comprising a first ligand LA of Formula I, is disclosed. In Formula I, ring A is a 5- or 6-membered ring; K is selected from a direct bond and a linking group; two adjacent ones of X1 to X4 are CR and are fused to form a structure of Formula II, each of X1 to X12 is CR or N; X is selected from a variety of linking groups; each R, R?, R?, and RA is hydrogen or a substituent; LA is coordinated to a metal M through the dashed lines in Formula I; and wherein (1) when X is CR?R?, X5 is CR; and (2) when X is O, S, Se, or NR?, at least one of the following is true: (a) the metal M is further coordinated to at least one substituted or unsubstituted acetylacetonate ligand; (b) at least one R comprises an electron withdrawing group; (c) at least two RA is not hydrogen or deuterium; or (d) at least one R is selected from a specific group of structures.

Abstract: A compound including ligand LA of Formula I, where LA includes at least one deuterium atom is provided. In Formula I, moiety A and B are monocyclic rings or polycyclic fused rings; K1 and K2 are direct bond, O, or S; and either (1) two RA or two RB substituents are joined together to form a fused ring structure of Formula II, where Formula II is joined to ring A or ring B, respectively, by the dashed lines, and Y is Se or GeR?R?; or (2) at least one RA or RB comprises a structure of Formula III, and Y is Se or GeR?R?; where Formula III is not fused to either of ring A or ring B. Formulations, OLEDs, and consumer products including the compound are also provided.

Abstract: A compound including a first ligand LA of Formula I, is disclosed. In Formula I, ring B is a 5- or 6-membered ring; X1, X2, and X3 are each CRA or N; R is a 5- or 6-membered carbocyclic or heterocyclic ring, which can be further fused or substituted; and (1) when ring B is an unfused 6-membered ring, X1 and X2 are N, and X3 is C; and (2) when ring B is a fused 6-membered ring, ring B has the structure of Formula II, In this structure, the wavy line indicates the point of connection to ring A; Q1 to Q6 are each C or N; and, when proviso (2) applies, (I) at least one of X1, X2, and X3 is N; or (II) R is two or more fused or unfused 5- or 6-membered carbocyclic or heterocyclic rings, or (III) at least ring A or R is substituted with a partially or fully deuterated alkyl or partially or fully deuterated cycloalkyl group.